# Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286

> **NCT05180162** · PHASE1 · COMPLETED · sponsor: **Thomas Hope** · enrollment: 16 (actual)

## Conditions studied

- Liver Fibrosis
- Pulmonary Fibrosis
- Myocardial Fibrosis

## Interventions

- **DRUG:** 68Ga-FAP-2286
- **PROCEDURE:** Positron Emission Tomography (PET)

## Key facts

- **NCT ID:** NCT05180162
- **Lead sponsor:** Thomas Hope
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-09
- **Primary completion:** 2024-05-28
- **Final completion:** 2024-05-28
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05180162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05180162, "Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05180162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*